Investors - Press Releases
|View printer-friendly version|
Tabula Rasa HealthCare and Strategic Solutions Network Partner on a Free COVID-19 Medication Safety Webinar
“There is an unprecedented interest in medications that may have potential to treat COVID-19,” states TRHC Chairman and CEO
Featured webinar speakers include: TRHC Chief Medical Officer
The presentation will identify the most widely discussed treatment options for COVID-19, the risk of drug-drug interactions and potential for major side effects. Additionally, the webinar will cover the relevant history and progression of COVID-19 and feature how simulations will become a good tool for COVID-19 medication management.
To participate in the webinar, please register here. This webinar is relevant for Individuals associated with health plans, Medicare Advantage plans, PACE, hospitals, health systems, ACOs, providers, and healthcare/health plan consultants.
To interview one of the webinar’s presenters, please contact
About Strategic Solutions Network
Strategic Solutions Network (SSN) is a privately-held business-to-business conference company based in
This press release includes forward-looking statements that we believe to be reasonable as of today’s date. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. These forward-looking statements include, among other things, our goals and expectations regarding the combined company and the integration of PW into TRHC, the expected synergies from the combined company and the expected financial and operating performance of TRHC following the completion of the acquisition. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the risk that we may not be able to achieve our expectations for the combined companies due to challenges in integration and inability to retain key employees; fluctuations in our financial results; the acceptance and use of our products and services by PACE organizations and pharmacies; the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; our ability to maintain relationships with a specified drug wholesaler; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; the requirements of being a public company; our ability to recognize the expected benefits from acquisitions on a timely basis or at all; and the other risk factors set forth from time to time in our filings with the
T: (312) 451-2157
Source: Tabula Rasa HealthCare, Inc.